Overview (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2020 |
Jun. 30, 2019 |
Dec. 31, 2016 |
Jun. 30, 2020 |
Jun. 30, 2019 |
Dec. 31, 2016 |
|
| Impairment charges for intangible assets | $ 12,000,000 | |||||
| Amortization expense | $ 1,000,000 | $ 800,000 | $ 2,100,000 | $ 1,600,000 | ||
| Barrett's and Thyroid Assets [Member] | ||||||
| Impairment charges for intangible assets | $ 11,600,000 | |||||
| Amortization expense | $ 100,000 | $ 100,000 | $ 200,000 | $ 200,000 | ||
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|